References
- KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
- CovertDRobinALAdjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprostCurr Med Res Opin200622597197616709319
- SherwoodMBCravenERChouCTwice-daily 0.2% brimonidine–0.5% timolol fixed-combination therapy vs mono-therapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: A 12-month randomized trialArch Ophthalmol200612491230123816966616
- Goñi FJ; Brimonidine/Timolol Fixed Combination Study Group12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertensionEur J Ophthalmol200515558159016167288
- FechtnerRDRealiniTFixed combinations of topical glaucoma medicationsCurr Opin Ophthalmol200415213213515021225
- RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
- NeelakantanAVaishnavHDIyerSASherwoodMBIs addition of a third or fourth antiglaucoma medication effective?J Glaucoma200413213013615097258
- CrichtonACSTimolol/brimonidine combination therapy in glaucoma managementClin Surg J Ophthalmol200523356359
- AhmedICEED II: An in-depth look at the latest findingsClin Surg J Ophthalmol20072515
- NixonDRYanDBChartrandJPPiemontesiRLSimonyiSHollanderDAThree-month, randomized, parallel-group comparison of brimonidine- timolol versus dorzolamide-timolol fixed-combination therapyCurr Med Res Opin20092571645165319476406
- The AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol2000130442944011024415
- LeskeMCHeijlAHusseinMBengtssonBHymanLKomaroffEEarly Manifest Glaucoma Trial GroupFactors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma TrialArch Ophthalmol20031211485612523884
- StewartWCDayDGSharpeEDDubinerHBHolmesKTStewartJAEfficacy and safety of timolol solution once daily vs timolol gel added to latanoprostAm J Ophthalmol1999128669269610612504
- HigginbothamEJFeldmanRStilesMDubinerHFixed Combination Investigative GroupLatanoprost and timolol combination therapy vs monotherapy: One-year randomized trialArch Ophthalmol2002120791592212096962
- PfeifferNEuropean Latanoprost Fixed Combination Study GroupA comparison of the fixed combination of latanoprost and timolol with its individual componentsGraefes Arch Clin Exp Ophthalmol20022401189389912486510
- OlanderKZimmermanTJDownesNSchoenfelderJXalacom/Latanoprost Study GroupSwitching from latanoprost to fixed- combination latanoprost-timolol: A 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertensionClin Ther200426101619162915598478
- DayDGHollanderDABrimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertensionCurr Med Res Opin20082451435144218402717
- FeldmanRMTannaAPGrossRLAdditivity Study GroupComparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%Ophthalmology200711471248125417509688
- WilliamsGCOrengo-NaniaSGrossRLIncidence of brimonidine allergy in patients previously allergic to apraclonidineJ Glaucoma20009323523810877374
- CravenERWaltersTRWilliamsRChouCCheethamJKSchiffmanRCombigan Study GroupBrimonidine and timolol fixed-combination therapy versus monotherapy: A 3-month randomized trial in patients with glaucoma or ocular hypertensionJ Ocul Pharmacol Ther200521433734816117698